Literature DB >> 17985966

Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity.

Amber E Barnato1, James E Bost, Maxwell H Farrell, Judith R Lave, Robert M Arnold, Doris M Rubio, Derek C Angus.   

Abstract

BACKGROUND: There are wide variations in hospital-level treatment intensity at the end of life that are not entirely explained by structural and market characteristics. Individual hospital microclimates must exist to perpetuate these practice variations.
OBJECTIVES: To determine whether a closed-ended survey based upon staff perceptions of informal norms regarding life prolongation, palliation, collaborative decision-making, and patient-doctor familiarity can identify hospital microclimates and to assess whether these norms are related to variation in end-of-life treatment intensity. DESIGN, PARTICIPANTS, AND MEASUREMENTS: Retrospective analysis of hospital discharge data at 11 purposively sampled Pennsylvania hospitals linked to a self-administered survey of 139 administrative and clinical staff fielded during site visits in 2004; measurements included year 2000 and 2004 rates of intensive care unit (ICU) admission, mechanical ventilation (MV), and hemodialysis among terminal hospitalizations at each hospital; survey respondent demographics, role, experience, and perceptions of their hospital's context and norms of end-of-life decision-making and treatment.
RESULTS: The purposively sampled hospitals exhibited wide variation in rates of ICU admission (38.2%-84.4%), MV (13.7%-41.4%), and hemodialysis (0%-9.2%) among terminal admissions. All 139 administered surveys were returned for a response rate of 100%. For each of 4 factors created from 19 survey items, staff responses varied more between hospitals than within hospitals (p < or = 0.03). One factor, patient-doctor familiarity, was inversely correlated with terminal ICU admission (p < 0.001) and MV (p = 0.03).
CONCLUSIONS: Discrimination of differences in microclimates related to norms of treatment intensity at the end of life is feasible, but greater specificity of measurement will be required to explain objective measures of terminal admission treatment intensity.

Entities:  

Mesh:

Year:  2007        PMID: 17985966      PMCID: PMC2880574          DOI: 10.1089/jpm.2006.0258

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  9 in total

1.  Organizational assessment in intensive care units (ICUs): construct development, reliability, and validity of the ICU nurse-physician questionnaire.

Authors:  S M Shortell; D M Rousseau; R R Gillies; K J Devers; T L Simons
Journal:  Med Care       Date:  1991-08       Impact factor: 2.983

2.  The influence of access to a private attending physician on the withdrawal of life-sustaining therapies in the intensive care unit.

Authors:  M H Kollef; S Ward
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

3.  Bereaved family member perceptions of quality of end-of-life care in U.S. regions with high and low usage of intensive care unit care.

Authors:  Joan M Teno; Vincent Mor; Nicholas Ward; Jason Roy; Brian Clarridge; John E Wennberg; Elliott S Fisher
Journal:  J Am Geriatr Soc       Date:  2005-11       Impact factor: 5.562

4.  The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

5.  The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

6.  Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.

Authors:  R S Broadhead; D D Heckathorn; D L Weakliem; D L Anthony; H Madray; R J Mills; J Hughes
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

7.  The performance of intensive care units: does good management make a difference?

Authors:  S M Shortell; J E Zimmerman; D M Rousseau; R R Gillies; D P Wagner; E A Draper; W A Knaus; J Duffy
Journal:  Med Care       Date:  1994-05       Impact factor: 2.983

8.  Improving intensive care: observations based on organizational case studies in nine intensive care units: a prospective, multicenter study.

Authors:  J E Zimmerman; S M Shortell; D M Rousseau; J Duffy; R R Gillies; W A Knaus; K Devers; D P Wagner; E A Draper
Journal:  Crit Care Med       Date:  1993-10       Impact factor: 7.598

9.  Private attending physician status and the withdrawal of life-sustaining interventions in a medical intensive care unit population.

Authors:  M H Kollef
Journal:  Crit Care Med       Date:  1996-06       Impact factor: 7.598

  9 in total
  16 in total

1.  Determinants of treatment intensity for patients with serious illness: a new conceptual framework.

Authors:  Amy S Kelley; R Sean Morrison; Neil S Wenger; Susan L Ettner; Catherine A Sarkisian
Journal:  J Palliat Med       Date:  2010-07       Impact factor: 2.947

2.  Quality of End-of-Life Care and Its Association with Nurse Practice Environments in U.S. Hospitals.

Authors:  Karen B Lasater; Douglas M Sloane; Matthew D McHugh; Linda H Aiken
Journal:  J Am Geriatr Soc       Date:  2018-12-02       Impact factor: 5.562

3.  Hospital Variation in Do-Not-Resuscitate Orders and End-of-Life Healthcare Use in the United States.

Authors:  Allan J Walkey; Amber E Barnato; Seppo T Rinne; Colin R Cooke; Meng-Shiou Shieh; Penelope S Pekow; Peter K Lindenauer
Journal:  Ann Am Thorac Soc       Date:  2017-09

4.  Variability Among US Intensive Care Units in Managing the Care of Patients Admitted With Preexisting Limits on Life-Sustaining Therapies.

Authors:  Joanna L Hart; Michael O Harhay; Nicole B Gabler; Sarah J Ratcliffe; Caroline M Quill; Scott D Halpern
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

5.  Religious coping and behavioral disengagement: opposing influences on advance care planning and receipt of intensive care near death.

Authors:  Paul K Maciejewski; Andrea C Phelps; Elizabeth L Kacel; Tracy A Balboni; Michael Balboni; Alexi A Wright; William Pirl; Holly G Prigerson
Journal:  Psychooncology       Date:  2011-03-29       Impact factor: 3.894

6.  Influence of patients' preferences and treatment site on cancer patients' end-of-life care.

Authors:  Alexi A Wright; Jennifer W Mack; Patricia A Kritek; Tracy A Balboni; Anthony F Massaro; Ursula A Matulonis; Susan D Block; Holly G Prigerson
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

7.  Providers' HIV-related avoidance attitude and patient satisfaction.

Authors:  Li Li; W Scott Comulada; Zunyou Wu; Yingying Ding; Weiming Zhu
Journal:  Health Expect       Date:  2011-06-14       Impact factor: 3.377

8.  Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries.

Authors:  Daniel D Matlock; Peter W Groeneveld; Steve Sidney; Susan Shetterly; Glenn Goodrich; Karen Glenn; Stan Xu; Lin Yang; Steven A Farmer; Kristi Reynolds; Andrea E Cassidy-Bushrow; Tracy Lieu; Denise M Boudreau; Robert T Greenlee; Jeffrey Tom; Suma Vupputuri; Kenneth F Adams; David H Smith; Margaret J Gunter; Alan S Go; David J Magid
Journal:  JAMA       Date:  2013-07-10       Impact factor: 56.272

9.  Variation in use of echocardiography among veterans who use the Veterans Health Administration vs Medicare.

Authors:  Vinay Kini; Fenton H McCarthy; Sheeva Rajaei; Andrew J Epstein; Paul A Heidenreich; Peter W Groeneveld
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

10.  Hospital staff attributions of the causes of physician variation in end-of-life treatment intensity.

Authors:  M R Larochelle; K L Rodriguez; R M Arnold; A E Barnato
Journal:  Palliat Med       Date:  2009-03-26       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.